Ionis制药公司首席执行官出售了相当大一部分股票,对公司股价略有影响。 Ionis Pharmaceuticals CEO sold a significant stock portion, slightly impacting the company’s share price.

Ionis制药公司首席执行官Brett P. Monia出售了13,242股公司股票,每股32.45美元,共计429,702.90美元。 Ionis Pharmaceuticals CEO, Brett P. Monia, sold 13,242 shares of the company’s stock for $32.45 each, totaling $429,702.90. 这次出售将他的所有权减少了5.69%,使他拥有价值约712万美元的219,526股股票。 This sale reduced his ownership by 5.69%, leaving him with 219,526 shares valued at about $7.12 million. 新闻报导后, Ionis的股份增加了0.23美元,达到32.13美元。 Shares of Ionis rose by $0.23 to $32.13 after the news. 该公司开发针对RNA的药物,包括脊椎肌肉萎缩和其他罕见疾病的治疗。 The company develops RNA-targeted drugs, including treatments for spinal muscular atrophy and other rare diseases.